Biological activities and possible dental application of three major groups of polyphenols

Journal of Pharmacological Sciences

Volumn 126, Issue 2, 2014, Pages 92-106

  Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Anti UV activity; Gingivitis; Oral carcinoma; Polyphenol; Viral infection

Indexed keywords

ANTHRAQUINONE; ASCORBIC ACID; BLEOMYCIN; CAMPTOTHECIN; CHLOROGENIC ACID; DOCETAXEL; EPIGALLOCATECHIN GALLATE; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; GALLIC ACID; GENISTEIN; GREEN TEA EXTRACT; ISOFLAVONE; ISOLIQUIRITIGENIN; KAEMPFEROL; LIGNIN CARBOHYDRATE COMPLEX; MELPHALAN; MITOMYCIN; N,N DIETHYLAMINOETHYL PARAMYLON; N,N DIMETHYLAMINOETHYL PARAMYLON; PENTAGALLOYL GLUCOSE; PEPLEOMYCIN; POLYPHENOL DERIVATIVE; PROCYANIDIN; PTEROCARPAN DERIVATIVE; RESVERATROL; TANNIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; IMMUNOLOGICAL ADJUVANT; LIGNIN; NUCLEOSOME; POLYPHENOL; SUNSCREEN;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER CELL LINE; CONCENTRATION RESPONSE; DENTAL PROCEDURE; DENTISTRY; DNA FRAGMENTATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; GINGIVITIS; HUMAN; IMMUNOPOTENTIATION; IN VITRO STUDY; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; RADIATION PROTECTION; REVIEW; ULTRAVIOLET RADIATION; CARCINOMA, SQUAMOUS CELL; CYTOPATHOGENIC EFFECT; DRUG EFFECTS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUTH NEOPLASMS; NUCLEOSOME; PATHOLOGY; TUMOR CELL LINE; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYTOPATHOGENIC EFFECT, VIRAL; DNA FRAGMENTATION; FLAVONOIDS; GINGIVITIS; HIV INFECTIONS; HUMANS; LIGNIN; MOUTH NEOPLASMS; NUCLEOSOMES; POLYPHENOLS; SUNSCREENING AGENTS; TANNINS; ULTRAVIOLET RAYS;

EID: 84909642647     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.14R04CR     Document Type: Review

References (122)

1. Okuda T, Yoshida T, Hatano T. Hydrolyzable tannins and related polyphenols. Fortschritte der Chemie organischer Naturstoffe. 1995;66:1-117.
2. Nomura T, Fukai T. Phenolic constituents of licorice (Glycyrrhiza species). Fortschr Chem Org Naturst. 1998;73:1-140.
3. Lewis NG, Yamamoto E. Lignin. Occurrence, biogenesis and biodegradation. Ann Rev Plant Physiol Plant Mol Biol. 1990;41:455-496.
4. Sakagami H, Chowdhury SA, Suzuki F, Hashimoto K, Hatano H, Takekawa H, et al. Tumor-specific cytotoxic activity of polyphenols, terpenoids, ketones and other synthetic compounds. Motohashi N. editor. Functional Polyphenols and Carotenes with Antioxidative Action. Lerala: Research Signpost; 2005. p. 133-176.
5. Sakagami H. Apoptosis-inducing activity and tumor-specificity of antitumor agents against oral squamous cell carcinoma. Jpn Dent Sci Rev. 2010;46:173-187.
6. Sakagami H, Hashimoto K, Suzuki F, Ogiwara T, Satoh K, Ito H, et al. Molecular requirement of lignin for expression of unique biological activity. Phytochemistry. 2005;66:2107-2119.
7. Sakagami H, Kushida T, Oizumi T, Nakashima H, Makino T. Distribution of lignin carbohydrate complex in plant kingdom and its functionality as alternative medicine. Pharmacol Ther. 2010;128:91-105.
8. John E. Building the better lab rat. Newsweek Global. 2014. Vol. 162. Issue 12. p. 1-5.
9. Suzuki R, Matsuo S, Sakagami H, Okada Y, Shirataki Y. Search of new cytotoxic crude materials against human oral squamous cell carcinoma using NMR metabolomics Anticancer Res. 2014;34:4117-4120.
10. Tamura N, Hirano K, Kishino K, Hashimoto K, Amano O, Shimada J, et al. Analysis of type of cell death induced by topoisomerase inhibitor (SN-38) in human oral squamous cell carcinoma cell lines. Anticancer Res. 2012;32:4823-4832.
11. Suzuki F, Hashimoto K, Kikuchi H, Nishikawa H, Matsumoto H, Shimada J, et al. Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin. Anticancer Res. 2005;25:887-894.
12. Sasaki M, Okamura M, Ideo A, Shimada J, Suzuki F, Ishihara M, et al. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin. Anticancer Res. 2006;26:3373-3380.
13. Iida S, Shimada J, Sakagami H. Cytotoxicity induced by docetaxel in human oral squamous cell carcinoma cell lines. In Vivo. 2013;27:321-332.
14. Sakagami H, Ishihara M, Hoshino Y, Ishikawa J, Mikami Y, Fukai T. Cytotoxicity of nocobactins NA-a, NA-b and their ferric complexes assessed by semiempirical molecular orbital methods. In Vivo. 2005;19:277-282.
15. Shirataki Y, Motohashi N, Tani S, Sakagami H, Satoh K, Nakashima H, et al. In vitro biological activity of prenylflavanone. Anticancer Res. 2001;21:275-280.
16. Shirataki Y, Tani S, Sakagami H, Satoh K, Nakashima H, Gotoh K, et al. Relationship between cytototoxic activity and radical intensity of isoflavones from Sophora Species. Anticancer Res. 2001;21:2643-2648.
17. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M, et al. Induction of apoptosis by flavones, flavonols (3-hydroxylflavones) and isoprenoid-substituted flavonoids in human oral tumor cell lines. Anticancer Res. 2000;20:271-278.
18. Fukai T, Sakagami H, Toguchi M, Takayama F, Iwakura I, Atsumi T, et al. Cytotoxic activity of low molecular weight polyphenols against human oral tumor cell lines. Anticancer Res. 2000;20:2525-2536.
19. Hou A-J, Fukai T, Shimazaki M, Sakagami H, Sun H-D, Nomura T. Benzophenones and xanthones with isoprenoid groups from Cudrania cochinchinensis. J Natural Products. 2001;64:65-70.
20. Shi Y-Q, Fukai T, Sakagami H, Kuroda J, Miyaoka R, Tamura M, et al. Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb. Anticancer Res. 2001;21:2847-2854.
21. Matsuta T, Sakagami H, Satoh K, Kanamoto T, Terakubo S, Nakashima H, et al. Biological activity of luteolin glycosides and tricin from Sasa senanensis Rehder. In Vivo. 2011;25:757-762.
22. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M, et al. Cytotoxic activity of hydrolysable tannins against human oral tumor cell lines - A possible mechanism. Phytomedicine. 2000;7:39-47.
23. Taniguchi S, Imayoshi Y, Kobayashi E, Takamatsu Y, Ito H, Hatano T, et al. Production of bioactive triterpenes by Eriobotyra Japonica calli. Phytochemistry. 2002;59:315-323.
24. Mimaki Y, Watanabe K, Ando Y, Sakuma C, Sashida Y, Furuya S, et al. Flavonol glycosides and steroidal saponins from the leaves of Cestrum nocturnum and their cytotoxic activity. J Nat Prod. 2001;64:17-22.
25. Furuya S, Takayama F, Mimaki Y, Sashida Y, Satoh K, Sakagami H. Cytotoxic activity of saponins from Camassia leichtlinii against human oral tumor cell lines. Anticancer Res. 2001;21:959-964.
26. Jiang Y, Kusama K, Satoh K, Takayama F, Watanabe S, Sakagami H. Induction of cell death by chlorogenic acid in human oral tumor cell lines. Phytomedicine. 2000;7:483-491.
27. Shirataki Y, Wakae M, Yamamoto Y, Hashimoto K, Satoh K, Ishihara M, et al. Cytotoxicity and radical modulating activity of isoflavones and isoflavanones from Sophora species. Anticancer Res. 2004;24:1481-1488.
28. Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, et al. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res. 2005;25:2055-2064.
29. Das U, Kawase M, Sakagami H, Ideo A, Shimada J, Molnar J, et al. 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel phamacophore displaying potent multidrug resistance reversal and selective cytotoxicity. Bioorg Med Chem. 2007;15:3373-3380.
30. Pati HN, Das U, Quail JW, Kawase M, Sakagami H, Dimmock JR. Cytotoxic 3,5-bis(arylidene)-4-piperidones and N-acetylanalogs displaying selective toxicity for malignant cells. Eur J Med Chem. 2008;43:1-7.
31. Das S, Das U, Sakagami H, Hashimoto K, Kawase M, Gorecki DK, et al. Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids. Bioorg Med Chem Lett. 2010;20:6464-6468.
32. Das U, Doroudi A, Gul HI, Pati HN, Kawase M, Sakagami H, et al. Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells. Bioorg Med Chem. 2010;18:2219-2224.
33. Das S, Das U, Sakagami H, Umemura N, Iwamoto S, Matsuta T, et al. Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties. Eur J Med Chem. 2012;51:193-199.
34. Sakagami H, Kawase M, Wakabayashi H, Kurihara T. Factors that affect the type of cell death induced by chemicals. Autophagy. 2007;3:493-495.
35. Nakayachi T, Yasumoto E, Nakano K, Morshed SRM, Hashimoto K, Kikuchi H, et al. Structure-activity relationships of α,β - unsaturated ketones as assessed by their cytotoxicity against oral tumor cells. Anticancer Res. 2004;24:737-742.
36. Yasumoto E, Nakano K, Nakayachi T, Morshed SRM, Hashimoto K, Kikuchi H, et al. Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines. Anticancer Res. 2004;24:755-762.
37. Nakano K, Nakayachi T, Yasumoto E, Morshed SRM, Hashimoto K, Kikuchi H, et al. Induction of apoptosis by β-diketones in human tumor cells. Anticancer Res. 2004;24:711-718.
38. Ideo A, Sasaki M, Nakamura C, Mori K, Shimada J, Kanda Y, et al. Cytotoxic activity of selected trifluoromethyl ketones against oral tumor cells. Anticancer Res. 2006;26:4335-4342.
39. Wakabayashi H, Nishishiro M, Arikawa S, Hashimoto K, Kikuchi H, Nishikawa H, et al. Cytotoxic activity of azulenequi nones against human oral tumor cell line. Anticancer Res. 2005;25:305-312.
40. 2 derivatives and prenylalcohols. Anticancer Res. 2008;28:151-158.
41. Kawase M, Sakagami H, Motohashi N, Hauer H, Chatterjee SS, Spengler G, et al. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity. In Vivo. 2005;19:705-712.
42. Kawase M, Sakagami H, Hashimoto K, Tani S, Hauer H, Chatterjee SS. Strucuture-cytotoxic activity relationships of simple hydroxylated coumarins. Anticancer Res. 2003;23:3243-3246.
43. Wakabayashi H, Hashiba K, Yokoyama K, Hashimoto K, Kikuchi H, Nishikawa H, et al. Cytotoxic activity of azulenes against human oral tumor cell lines. Anticancer Res. 2003;23:4747-4756.
44. Akatsu Y, Ohshima N, Yamagishi Y, Nishishiro M, Wakabayashi H, Kurihara T, et al. Apoptosis-inducing activity of trihaloacetylazulenes against human oral tumor cell lines. Anticancer Res. 2006;26:1917-1924.
45. Sekine T, Takahashi J, Nishishiro M, Arai A, Wakabayashi H, Kurihara T, et al. Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines. Anticancer Res. 2007;27:133-144.
46. Ueki J, Sakagami H, Wakabayashi H. Anti-UV activity of newly synthesized water-soluble azulenes. In Vivo. 2013;27:119-126.
47. Wakabayashi H, Yokoyama K, Hashiba K, Hashimoto K, Kikuchi H, Nishikawa H, et al. Cytotoxic activity of tropolones against human oral tumor cell lines. Anticancer Res. 2003;23:4757-4764.
48. Narita T, Suga A, Kobayashi M, Hashimoto K, Sakagami H, Motohashi N, et al. Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives. Anticancer Res. 2009;29:1123-1130.
49. Murayama H, Miyahara K, Wakabayashi H, Kurihara T, Hashimoto K, Amano O, et al. Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines. Anticancer Res. 2008;28:1069-1078.
50. Engi H, Sakagami H, Kawase M, Parecha A, Manvar D, Kothari H, et al. Tumor-specific cytotoxicity and MDR-reversal activity of dihydropyridines. In Vivo. 2006;20:637-644.
51. Terasawa K, Sugita Y, Yokoe I, Fujisawa S, Sakagami H. Cytotoxic activity of 2-aminomethylene-3(2H)-benzofuranone against human oral tumor cell lines. Anticancer Res. 2001;21:3371-3376.
52. Sugita Y, Hosoya H, Terasawa K, Yokoe I, Fujisawa S, Sakagami H. Cytotoxic activity of benzothiepins against human oral tumor cell lines. Anticancer Res. 2001;21:2629-2632.
53. Terasawa K, Sugita Y, Yokoe I, Fuijsawa S, Sakagami H. Cytotoxic activity of 5-benzoylimidazole and related compounds against human oral tumor cell lines. Anticancer Res. 2001;21:1081-1086.
54. Takekawa F, Nagumo T, Shintani S, Hashimoto K, Kikuchi H, Katayama T, et al. Tumor-specific cytotoxic activity and type of cell death induced by 4-trifluoromethylimidazoles in human oral squamous cell carcinoma cell lines. Anticancer Res. 2007;27:4065-4070.
55. Kawase M, Tanaka T, Kan H, Tani S, Nakashima H, Sakagami H. Biological activity of 3-formylchromones and related compounds. In Vivo. 2007;21:829-834.
56. Suzuki F, Hashimoto K, Ishihara M, Westman G, Samuelsson K, Kawase M, et al. Tumor-specificity and type of cell death induced by phenoxazines. Anticancer Res. 2007;27:4233-4238.
57. Inoue K, Kulsum I, Chowdhury SA, Fujisawa S, Ishihara M, Yokoe I, et al. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res. 2005;25:4053-4060.
58. Kishino K, Hashimoto K, Amano O, Kochi M, Sakagami H. Tumor-specificic cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate. Anticancer Res. 2088;28:2577-2584.
59. Ariyoshi-Kishino K, Hashimoto, K, Amano O, Kochi M, Sakagami H. Tumor-specific cytotoxicity and type of cell death induced by benzaldehyde. Anticancer Res. 2010;30:5069-5076.
60. Takano A, Hashimoto K, Ogawa M, Koyanagi J, Kurihara T, Wakabayashi H, et al. Tumor-specific cytotoxicity and type of cell death induced by naphtha[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure. Anticancer Res. 2009;29:455-464.
61. Momoi K, Sugita Y, Ishihara M, Satoh K, Kikuchi H, Hashimoto K, et al. Cytotoxic activity styrylchromones against human tumor cell lines. In Vivo. 2005;19:157-164.
62. Kobayashi K, Ohno S, Uchida S, Amano O, Sakagami H, Nagasaka H. Cytotoxicity and type of cell death induced by local anesthetics against human oral normal and tumor cells. Anticancer Res. 2012;32:2925-2934.
63. Morshed SRM, Hashimoto K, Murotani Y, Kawase M, Shah A, Satoh K, et al. Tumor-specific cytotoxicity of 3,5-dibenzoyl-1,4-dihydropyridines. Anticancer Res. 2005;25:2033-2038.
64. Shimada C, Uesawa Y, Ishii-Nozawa R, Ishihara M, Kagaya H, Kanamto T, et al. Quantitative structure-cytotoxicity relationship of 3-styrylchromones. Anticancer Res. 2014. In press.
65. Sakagami H, Ohkoshi E, Amano S, Satoh K, Kanamoto T, Terakubo S, et al. Efficient utilization of plant resources by alkaline extraction. Altern Integr Med. 2013;2:133.
66. Ohno H, Miyoshi S, Araho D, Kanamoato T, Terakubo S, Nakashima H, et al. Efficient utilization of licorice root by alkaline extraction. In Vivo. 2014;28:785-794.
67. Lai PK, Donovan J, Takayama H, Sakagami H, Tanaka A, Konno K, et al. Modification of human immunodeficiency viral replication by pine cone extacts. AIDS Res Human Retroviruses. 1990;6:205-217.
68. Satoh K, Kihara T, Ida Y, Sakagami H, Koyama N, Premanathan M, et al. Radical modulation activity of pine cone extracts of Pinus elliottii var. Elliottii. Anticancer Res. 1999;19:357-364.
69. Sakagami H, Yoshihara M, Fujimaki M, Wada C, Komatsu N, Nakashima H, et al. Effect of pine seed shell extract on microbial and viral infection. In Vivo. 1992;6:13-16.
70. Manabe H, Sakagami H, Ishizone H, Kusano H, Fujimaki M, Wada C, et al. Effects of Catuaba extracts on microbial and HIV infection. In Vivo. 1992;6:161-166.
71. Sakagami H. Satoh K, Fukamachi H, Ikarashi T, Shimizu A, Yano K, et al. Anti-HIV and vitamin C-synergized radical scavenging activity of cacao husk lignin fractions. In Vivo. 2008;22:327-332.
72. Sakagami H, Kawano M, Thet MM, Hashimoto K, Satoh K, Kanamoto T, et al. Anti-HIV and immunomodulation activities of cacao mass lignin carbohydrate complex. In Vivo. 2011;25:229-236.
73. Kawano M, Sakagami H, Satoh K, Shioda S, Kanamoto T, Terakubo S, et al. Lignin-like activity of Lentinus edodes mycelia extract (L.E.M). In Vivo. 2010;24:543-552.
74. Sakagami H, Asano K, Satoh K, Takahashi K, Kobayashi M, Koga N, et al. Anti-stress, anti-HIV and vitamin C-synergized radical scavenging activity of mulberry juice fractions. In Vivo. 2007;21:499-506.
75. Sakagami H, Zhou Li, Kawano M, Thet MM, Takana S, Machino M, et al. Multiple biological complex of alkaline extract of the leaves of Sasa senanensis Rehder. In Vivo. 2010;24:735-744.
76. Koizumi N, Sakagami H, Utsumi A, Fujinaga S, Takeda M, Asano K, et al. Anti-HIV (human immunodeficiency virus) activity of sulfated paramylon. Antiviral Res. 1993;21:1-14.
77. Kato T, Horie N, Matsuta T, Umemura N, Shimoyama T, Kaneko T, et al. Anti-UV/HIV activity of Kampo medicines and constituent plant extracts. In Vivo. 2012;26:1007-1013.
78. Nakashima H, Murakami T, Yamamoto N, Sakagami H, Tanuma S, Hatano T, et al. Inhibition of human immunodeficiency viral replication by tannins and related compounds. Antiviral Res. 1992;18:91-103.
79. Lai PK, Oh-hara T, Tamura Y, Kawazoe Y, Konno K, Sakagami H, et al. Polymeric phenylpropenoids are the active components in the pine cone extract that inhibit the replication of type-1 human immunodeficiency virus in vitro. J Gen Appl Microbiol. 1992;38:303-323.
80. Takayama H, Bradley G, Lai PK, Tamura Y, Sakagami H, Tanaka A, et al. Inhibition of human immunodeficiency virus forward and reverse transcription by PC6, a natural product from cones of pine trees. AIDS Res Human Retroviruses. 1991;7:349-357.
81. Nakashima H, Murakami T, Yamamoto N, Naoe T, Kawazoe Y, Konno K, et al. Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins. Chem Pharm Bull. 1992;40:2102-2105.
82. Sakagami H, Takeda M, Kawazoe Y, Nagata K, Ishihama A, Ueda M, et al. Anti-influenza virus activity of a lignin fraction from cone of Pinus parviflora Sieb. et Zucc. In Vivo. 1992;6:491-496.
83. Nagata K, Sakagami H, Harada H, Nonoyama M, Ishihara A, Konno K. Inhibition of influenza virus infection by pine cone antitumor substances. Antiviral Res. 1990;13:11-22.
84. Harada H, Sakagami H, Nagata K, Oh-hara T, Kawazoe Y, Ishihama A, et al. Possible involvement of lignin structure in anti-influenza virus activity. Antiviral Res. 1991;15:41-50.
85. Sakagami H, Nagata K, Ishihama A, Oh-hara T, Kawazoe Y. Anti-influenza virus activity of synthetically polymerized phenylpropenoids. Biochem Biophys Res Commun. 1990;172:1267-1272.
86. Fukuchi K, Sakagami H, Ikeda M, Kawazoe Y, Oh-hara T, Konno K, et al. Inhibition of herpes simplex virus infection by pine cone antitumor substances. Anticancer Res. 1989;9:313-318.
87. Mukoyama A, Ushijima H, Unten S, Nishimura S, Yoshihara M, Sakagami H. Effect of pine seed shell extract on rotavirus and enterovirus infections. Letters in Appl Microbiol. 1991;13:109-111.
88. Ono M, Kantoh K, Ueki J, Shimada A, Wakabayashi H, Matsuta T, et al. Quest for anti-inflammatory substances using IL-1β-stimulated gingival fibroblasts. In Vivo. 2011;25:763-768.
89. Sakagami H, Ohkoshi E, Matsuta T, Tanaka S, Matsumoto M, Yasui T, et al. Antiviral materials. In: Sakagami H, editor. Toothpaste containing alkaline extract of Sasa senanensis Rehder leaves. Oral health care and anti-aging. Osaka: CMC Publishing Co., Ltd.; 2013. p. 217-243. (text in Japanese)
90. Horie N, Hashimoto K, Hino S, Kato T, Shimoyama T, Kaneko T, et al. Anti-inflammatory Potential of Rikkosan based on IL-1β network through macrophage to oral tissue cells. In Vivo. 2014;28:563-570.
91. Ara T, Meda Y, Fujinami Y, Imamura Y, Hattori T, Wang P-L. Preventive effects of a Kampopo medicine, Shosaikoto, on inflammaory responses in LPS-treated human gingival fibroblasts. Bio Pharm Bull. 2008;36:1141-1144.
92. Ara T, Hongo K, Fujinami Y, Hattori T, Imamura Y, Wang P-L. Preventive effects of a Kampo medicine, Orento on inflammatory responses in lipopolysaccharide treated human gingival fibroblasts. Bull Pharm Bull. 2010;33:611-616.
93. Liao J, Azelmat J, Zhao L, Yoshioka M, Hinode D, Grenier D. The Kampo medicine Rokumigan possesses antibiofilm, anti-inflammatory, and wound healing properties. BioMed Res Int. 2014. doi:10.1155/2014/436206.
94. Hu P, Huang P, Chen MW. Curcumin attenuates cyclooxygenase-2 expression via inhibition of the NF-κB pathway in lipopolysaccharide-stimulated human gingival fibroblasts. Cell Biol Int. 2013;37:443-448.
95. + channels by curcumin in Jurkat-T cells. J Pharmacol Sci. 2011;115:144-154.
96. 2, cyclooxygenases, lipoxygenase and proinflammatory cytokines. Bioorg Med Chem. 2014;22:4151-4161.
97. Kraft S, Granter SR. Molecular pathology of skin neoplasms of the head and neck. Arch Pathol Lab Med. 2014;138:759-787.
98. Nanbu T, Shimada J, Kobayashi M, Hirano K, Koh T, Machino M, et al. Anti-UV activity of lignin-carbohydrate complex and related compounds. In Vivo. 2013;27:133-140.
99. Nanbu T, Matsuta T, Sakagami H, Shimada J, Maki J, Makino T. Anti-UV activity of Lentinus edodes mycelia extract (LEM). In Vivo. 2011;25:733-740.
100. Matsuta T, Sakagami H, Kitajima M, Oizumi H. Oizumi T. Anti-UV activity of alkaline extracts of the leaves of Sasa senanensis Rehder. In Vivo. 2011;25:751-755.
101. Komaki N, Watanabe T, Ogasawara A, Sato N, Mikami T, Matsumoto T. Antifungal mechanism of hinokithio against Candida albicans. Biol Pharm Bull. 2008;31:735-737.
102. Nakamura M, Fujibayashi T, Tominaga A, Satoh N, Kawarai T, Shinozuka O, et al. Hinokithiol inhibits Candica albicans adherence to oral epithelial cells. J Oral Biosci. 2011;52:42-50.
103. Tamura M, Saito H, Kikuchi K, Ishigami T, Toyama Y, Takami M, et al. Antimicrobial activity of gel-entrapped catechins toward oral microorganism. Bio Pharm Bull. 2011;34:638-643.
104. Satoh K, Ida Y, Ishihara M, Sakagami H. Interaction between sodium ascorbate and polyphenols. Anticancer Res. 1999;19:4177-4186.
105. Sakagami H, Satoh K, Ida Y, Hosaka M, Arakawa H, Maeda M. Interaction between sodium ascorbate and dopamine. Free Radic Biol Med. 1998;25:1013-1020.
106. Sakagami H, Satoh K, Hakeda Y, Kumegawa M. Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol. 2000;46:129-143.
107. Sakagami H, Amano S, Kikuchi H, Nakamura Y, Kuroshita R, Watanabe S, et al. Antiviral, antibacterial and vitamin C-synergized radical scavenging activity of Sasa senanensis Rehder extract. In Vivo. 2008;22:471-476.
108. Sakagami H, Satoh K, Aiuchi T, Nakaya K, Takeda M. Stimulation of ascorbate-induced hypoxia by lignin. Anticancer Res. 1997;17:1213-1216.
109. Kushida T, Makino T, Tomomura M, Tomomura A, Sakagami H. Enhancement of dectin-2 gene expression by lignin-carbohydrate complex from Lendinus edodes extract (LEM) in mouse macrophage-like cell line. Anticancer Res. 2011;31:1241-1248.
110. Brown GD, Gordon S. Immune recognition. A new receptor for β-glucans. Nature. 2001;413:36-37.
111. McGreal EP, Rosas M, Brown GD, Zamze S, Wong SY, Goldon S, et al. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology. 2006;16:422-430.
112. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity. 2010;32:681-691.
113. López BSG, Yamamoto M, Utsumi K, Aratsu C, Sakagami H. Clinical pilot study of lignin-ascorbic acid combination treatment of herpes simplex virus. In Vivo. 2009;23:1011-1016.
114. Matsuta T, Sakagami H, Tanaka S, Machino M, Tomomura M, Tomomura A, et al. Pilot clinical study of Sasa senanensis Rehder leaf extract treatment on lichenoid dysplasia. In Vivo. 2012;26:957-962.
115. Oka Y, Iwai S, Amano H, Irie Y, Yatomi K, Ryu K, et al. Tea polyphenols inhibit rat osteoclast formation and differentiation. J Pharmacol Sci. 2012;118:55-64.
116. Kiyoura Y. Antimicrobial activity of gel-entrapped hinokitiol. In: Sakagami H ed., Oral Health Care and Anti-aging. Osaka: CMC Publishing Co., Ltd.; 2013. p. 110-115. (text in Japanese)
117. Miyamoto M, Sakagami H, Minagawa K, Kikuchi H, Nishikawa H, Satoh K, et al. Tumor-specificity and radical scavenging activity of poly-herbal formula. Anticancer Res. 2002;22:1217-1224.
118. Sakagami H, Matsuta T. Chocolate in health and nutrition. Heidelberg: Springer; 2012. p. 247-262.
119. Sakagami H, Asano K, Yoshida T, Kawazoe Y. Organ distribution and toxicity of lignin. In Vivo. 1999;13:41-44.
120. Ehihara S, Kohzuki M, Sumi Y, Ebihara T. Sensory stimulation to improve swallowing reflex and prevent aspination in elderly dysphagic people. J Pharmacol Sci. 2011;115:99-104.
121. Matsumoto K, Zhao Q, Niu Y, Fujiwara H, Tanaka K, Sasaki-Hamada S, et al. Kampo formulation, Chitosan, Yokukansan, for dementia therapy: existing clinical and preclinical evidence. J Pharmacol Sci. 2013;122:257-269.
122. Zhang G, Li P, Purkayastha S, Tang Y, Zhang H, Yin Y, et al. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature. 2013;497:211-216.